Summit Trail Advisors LLC Purchases 81 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Summit Trail Advisors LLC boosted its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 11.5% in the third quarter, Holdings Channel.com reports. The firm owned 784 shares of the company’s stock after acquiring an additional 81 shares during the period. Summit Trail Advisors LLC’s holdings in IDEXX Laboratories were worth $396,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Ridgewood Investments LLC bought a new position in shares of IDEXX Laboratories in the 2nd quarter valued at about $27,000. Institutional & Family Asset Management LLC bought a new position in shares of IDEXX Laboratories in the 2nd quarter valued at about $28,000. E Fund Management Hong Kong Co. Ltd. grew its holdings in shares of IDEXX Laboratories by 5,700.0% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 58 shares of the company’s stock valued at $29,000 after acquiring an additional 57 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC grew its holdings in shares of IDEXX Laboratories by 750.0% in the 3rd quarter. Mowery & Schoenfeld Wealth Management LLC now owns 68 shares of the company’s stock valued at $34,000 after acquiring an additional 60 shares in the last quarter. Finally, Strategic Investment Solutions Inc. IL bought a new position in shares of IDEXX Laboratories in the 2nd quarter valued at about $36,000. Institutional investors own 87.84% of the company’s stock.

IDEXX Laboratories Trading Down 2.6 %

Shares of IDXX stock opened at $417.32 on Wednesday. The firm has a 50 day moving average price of $457.31 and a two-hundred day moving average price of $479.47. The company has a quick ratio of 1.03, a current ratio of 1.42 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $34.17 billion, a PE ratio of 40.24, a price-to-earnings-growth ratio of 3.64 and a beta of 1.36. IDEXX Laboratories, Inc. has a 12-month low of $398.50 and a 12-month high of $583.39.

IDEXX Laboratories (NASDAQ:IDXX) last issued its quarterly earnings data on Thursday, October 31st. The company reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.69 by $0.11. The firm had revenue of $975.50 million during the quarter, compared to the consensus estimate of $980.32 million. IDEXX Laboratories had a net margin of 22.53% and a return on equity of 55.42%. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same period last year, the business posted $2.53 earnings per share. As a group, analysts predict that IDEXX Laboratories, Inc. will post 10.43 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have recently weighed in on IDXX. Barclays decreased their price objective on IDEXX Laboratories from $570.00 to $481.00 and set an “overweight” rating for the company in a report on Monday, November 4th. JPMorgan Chase & Co. decreased their price objective on IDEXX Laboratories from $630.00 to $575.00 and set an “overweight” rating for the company in a report on Friday, October 11th. Stifel Nicolaus cut their target price on shares of IDEXX Laboratories from $510.00 to $500.00 and set a “hold” rating for the company in a research note on Thursday, October 10th. Finally, Piper Sandler reiterated a “neutral” rating and issued a $435.00 target price (down from $520.00) on shares of IDEXX Laboratories in a research note on Monday, November 4th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $552.38.

IDEXX Laboratories Company Profile

IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.